SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: HOLLIS-EDEN PHARMACEUTICALS
Firm Income Reported for This Client
$375K
Not substituted for client expenses
Summary
HOLLIS-EDEN PHARMACEUTICALS is an organization. Its political footprint includes $375K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Science/Technology. Political activity spans from 2003 to 2007.